Constellium (CSTM) Tops Q1 EPS by 14c; offers outlook

Constellium (NYSE: CSTM) reported Q1 EPS of EUR0.26, EUR0.14 better than the analyst estimate of EUR0.12. Revenue for the quarter came in at EUR1.98 billion versus the consensus estimate of EUR1.79 billion.

Outlook

Based on our current outlook, for 2025 we expect Adjusted EBITDA, which excludes the non-cash impact of metal price lag, to be in the range of $600 million to $630 million and Free Cash Flow in excess of $120 million. For 2028, we expect Adjusted EBITDA, which excludes the non-cash impact of metal price lag, of $900 million and Free Cash Flow of $300 million.

For earnings history and earnings-related data on Constellium (CSTM) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Macquarie Upgrades DiDi Global (DIDIY) to Outperform